Research has shown that ICA downregulates peroxisome proliferator-activated receptor gamma (PPARγ) expression, promoting osteogenic differentiation and inhibiting adipogenic differentiation in ...
Perpetuation then results from the effects of these stimuli on maintaining the activated phenotype and generating fibrosis. The earliest changes in stellate cells are likely to result from ...
Leriglitazone is Minoryx Therapeutics’s novel orally bioavailable and selective PPAR gamma agonist ... and the first in the peroxisome proliferator-activated receptor (PPAR) agonist class.
In other words, "the cannabinoid receptors were seen to be activated and the acetylcholine levels in the brain to be increased. The drug restored the cholinergic system and improved memory", added ...